Catalyst Pharmaceuticals (CPRX) Work In Process (2023 - 2026)

Catalyst Pharmaceuticals (CPRX) has 4 years of Work In Process data on file, last reported at $2.8 million in Q1 2026.

• For the quarter ending Q1 2026, Work In Process fell 34.42% year-over-year to $2.8 million; the trailing twelve-month figure through Mar 2026 stood at $2.8 million (down 34.42% YoY), and the FY2025 full-year result was $3.9 million, up 12.37% from the prior year.
• Work In Process for Q1 2026 stood at $2.8 million, down from $3.9 million in the prior quarter.
• Across five years, Work In Process topped out at $5.3 million in Q2 2025 and bottomed at $2.8 million in Q1 2026.
• The 4-year median for Work In Process is $4.0 million (2024), against an average of $4.1 million.
• The widest annual swing landed in 2025, when Work In Process surged 32.89%; it then tumbled 34.42% in 2026.
• A 4-year view of Work In Process shows it stood at $4.6 million in 2023, then decreased by 24.67% to $3.4 million in 2024, then grew by 12.37% to $3.9 million in 2025, then fell by 28.44% to $2.8 million in 2026.
• The last three Work In Process figures came in at $2.8 million (Q1 2026), $3.9 million (Q4 2025), and $4.6 million (Q3 2025), per Business Quant data.

Peer Comparison